Bilateral Oophorectomy and Breast Cancer Risk inBRCA1andBRCA2Mutation Carriers

Hormone replacement therapy after menopause and risk of breast cancer in BRCA1 mutation carriers: a case–control study

(2016) Joanne Kotsopoulos et al.   BREAST CANCER RESEARCH AND TREATMENT

Adjuvant endocrine therapy for early breast cancer: a systematic review of the evidence for the 2014 Cancer Care Ontario systemic therapy guideline

(2015) O.C. Freedman et al.   Current Oncology

Breast Cancer Risk After Salpingo-Oophorectomy in Healthy BRCA1/2 Mutation Carriers: Revisiting the Evidence for Risk Reduction

(2015) B. A. M. Heemskerk-Gerritsen et al.   JNCI-Journal of the National Cancer Institute

Breast Cancer Risk After Salpingo-Oophorectomy in Healthy BRCA1/2 Mutation Carriers: Revisiting the Evidence for Risk Reduction

(2015) B. A. M. Heemskerk-Gerritsen et al.   JNCI-Journal of the National Cancer Institute

Effect of Oophorectomy on Survival After Breast Cancer inBRCA1andBRCA2Mutation Carriers

(2015) Kelly Metcalfe et al.   JAMA Oncology

Duration of tamoxifen use and the risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers

(2014) Jacek Gronwald et al.   BREAST CANCER RESEARCH AND TREATMENT

Timing of oral contraceptive use and the risk of breast cancer in BRCA1 mutation carriers

(2014) Joanne Kotsopoulos et al.   BREAST CANCER RESEARCH AND TREATMENT

Impact of Oophorectomy on Cancer Incidence and Mortality in Women With a BRCA1 or BRCA2 Mutation

(2014) Amy P.M. Finch et al.   JOURNAL OF CLINICAL ONCOLOGY

Ovarian Conservation at the Time of Hysterectomy and Long-Term Health Outcomes in the Nurses’ Health Study

(2014) William H. Parker et al.   OBSTETRICS AND GYNECOLOGY

Oophorectomy and Hysterectomy and Cancer Incidence in the Cancer Prevention Study-II Nutrition Cohort

(2014) Mia M. Gaudet et al.   OBSTETRICS AND GYNECOLOGY

Tamoxifen and Risk of Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers

(2013) Kelly-Anne Phillips et al.   JOURNAL OF CLINICAL ONCOLOGY

Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACE

(2013) Nasim Mavaddat et al.   JNCI-Journal of the National Cancer Institute

Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA)

(2012) N. Mavaddat et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Predictors of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers

(2011) K Metcalfe et al.   BRITISH JOURNAL OF CANCER

Circulating sex hormones and breast cancer risk factors in postmenopausal women: reanalysis of 13 studies

(2011)   BRITISH JOURNAL OF CANCER

Association of Risk-Reducing Surgery in BRCA1 or BRCA2 Mutation Carriers With Cancer Risk and Mortality

(2010) Susan M. Domchek   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Meta-analysis of Risk Reduction Estimates Associated With Risk-Reducing Salpingo-oophorectomy in BRCA1 or BRCA2 Mutation Carriers

(2009) T. R. Rebbeck et al.   JNCI-Journal of the National Cancer Institute

Risk-Reducing Salpingo-Oophorectomy for the Prevention of BRCA1- and BRCA2-Associated Breast and Gynecologic Cancer: A Multicenter, Prospective Study

(2008) Noah D. Kauff et al.   JOURNAL OF CLINICAL ONCOLOGY